It's easy to become discouraged from trading, with the numerous distractions we face daily, and the setbacks that tamper with the domestic market. But, believe it or not, there are some stocks that both aren't heavily influenced by healthcare reform or thick-headed banks and are less susceptible to the heated bullish-versus-bearish arguments. Interestingly, that means it may be time to take our business (and investing) investing elsewhere.
IN PICTURES: Learn To Invest In 10 Steps
Bank On Canada
The Bank of Nova Scotia (NYSE:BNS): From a trader's perspective, the way shares of BNS seem to have it a ceiling at $45.80 of late is a worry, though it's only a short-term concern, if the company's numbers have anything to do with it. The 12-month P/E of 17 and the forward-looking P/E of 13.5 are solid, but that's not the attractive part - net margins are consistently in the 25% area.
As for sustainability of said strength, Canada's unemployment rate fell from 8.7% to 8.4% last month thanks to the addition of 30,000 jobs. Time to head north with some capital.
More in the North
Biovail Corp. (NYSE:BVF): Speaking of northern neighbors, when's the last time you came across a biotech company that was not only consistently profitable, but actually increased EPS during a recession? Biovail did.
Better still, there's something in the pipeline that can keep the streak going. Though the co-venture with Acadia Pharmaceuticals to develop pimavanserin as a treatment for Parkinson's disease fell short of expectation, the drug has shown solid efficacy in trials as a treatment for schizophrenia, a market estimated to be worth more than $4 billion annually.
Empresa Brasileira de Aeronautica S.A. (NYSE:ERJ): You'll know the company better as Embraer, the Brazilian small plane and commuter jet manufacturer.
Though this a recovery play, facts are facts, and Embraer delivered 19% more aircrafts during Q3 of 2009 than it did in Q3 of 2008.
As supporting evidence, Morgan Stanley analyst Heidi Wood recently wrote that used jet sales were picking up, as were orders for higher-end business jets. China has also opened its airspace to more private jets, which could further drive demand that simply wasn't allowed to exist before.
Mobile Telesystems OJSC (NYSE:MBT): The Russian mobile telecom provider became a mobile/land-line provider on Tuesday with the purchase of COMSTAR-UTS. While a comparable wireless/land-line combination between Vimpel (NYSE:VIP) and Golden Telecom is finally starting to pay off, a mirror of that deal isn't the compelling part - the telecom market in Russia is pretty much tapped by now.
The reason the newly-combined outfits make for an exciting investment is simply that this union gives Mobile Telesystems an entry into broadband - one of the region's underdeveloped (but fast growing) markets.
Luck of the Irish
Covidien PLC (NYSE:COV): Ireland's medical device and equipment supplier recently unveiled a wound closure device, the V-loc. The device reduces the time needed to suture by 30% to 50%, and avoids some of the potential complications that can arise with suture knots or staples.
While the technology is welcomed, as with so many so-called medical marvels, associating any potential revenue for the V-loc is ill-advised - there's just no feasible way to say what the thing is worth to Covidien.
So why's the stock on the ADR pick list? For the reason investors would want to own any other stock - consistent, reliable profits, and a forward-looking price multiple of 13.3. The V-loc is just a potential steroid on top of the success the company's already creating.
The Bottom Line
There you go - five ideas that will let you own quality names while avoiding the sea sickening ebb and flow most American stocks seem to be shoving down our throats of late.
On that note, you might want to take a look at the charts of these same five picks. With the exception of Embraer, each of them has made steady, consistent progress as the global economy has been reawakened (and even ERJ's volatility has been decidedly bullish). Not that a lack of volatility is the secret to success, but it sure makes it easier to hold onto these stocks when the U.S. market turns choppy. (For more, check out our ADR Basics Tutorial.)
Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!